nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—CYP3A4—bone cancer	0.52	1	CbGaD
Enalapril—SLC22A7—Methotrexate—bone cancer	0.0984	0.283	CbGbCtD
Enalapril—SLCO1A2—Methotrexate—bone cancer	0.069	0.199	CbGbCtD
Enalapril—SLC22A8—Methotrexate—bone cancer	0.0601	0.173	CbGbCtD
Enalapril—SLC22A6—Methotrexate—bone cancer	0.0418	0.12	CbGbCtD
Enalapril—ABCB1—Cisplatin—bone cancer	0.0287	0.0827	CbGbCtD
Enalapril—ABCB1—Doxorubicin—bone cancer	0.0192	0.0554	CbGbCtD
Enalapril—ABCB1—Methotrexate—bone cancer	0.0186	0.0537	CbGbCtD
Enalapril—CYP3A4—Doxorubicin—bone cancer	0.0115	0.0332	CbGbCtD
Enalapril—Captopril—MMP2—bone cancer	0.00464	0.583	CrCbGaD
Enalapril—Captopril—MMP9—bone cancer	0.00305	0.383	CrCbGaD
Enalapril—Dysuria—Methotrexate—bone cancer	0.000281	0.00225	CcSEcCtD
Enalapril—Neutropenia—Methotrexate—bone cancer	0.000281	0.00225	CcSEcCtD
Enalapril—Paraesthesia—Cisplatin—bone cancer	0.00028	0.00224	CcSEcCtD
Enalapril—Upper respiratory tract infection—Methotrexate—bone cancer	0.000279	0.00223	CcSEcCtD
Enalapril—Eosinophilia—Epirubicin—bone cancer	0.000279	0.00223	CcSEcCtD
Enalapril—Dyspnoea—Cisplatin—bone cancer	0.000278	0.00222	CcSEcCtD
Enalapril—Erectile dysfunction—Methotrexate—bone cancer	0.000277	0.00221	CcSEcCtD
Enalapril—Dry skin—Doxorubicin—bone cancer	0.000276	0.00221	CcSEcCtD
Enalapril—Pancreatitis—Epirubicin—bone cancer	0.000276	0.0022	CcSEcCtD
Enalapril—Orthostatic hypotension—Doxorubicin—bone cancer	0.000275	0.0022	CcSEcCtD
Enalapril—Photosensitivity reaction—Methotrexate—bone cancer	0.000274	0.00219	CcSEcCtD
Enalapril—Angina pectoris—Epirubicin—bone cancer	0.000274	0.00219	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000271	0.00217	CcSEcCtD
Enalapril—Decreased appetite—Cisplatin—bone cancer	0.000271	0.00216	CcSEcCtD
Enalapril—Bronchitis—Epirubicin—bone cancer	0.000271	0.00216	CcSEcCtD
Enalapril—Nateglinide—CYP3A4—bone cancer	0.00027	0.034	CrCbGaD
Enalapril—Pneumonia—Methotrexate—bone cancer	0.00027	0.00215	CcSEcCtD
Enalapril—Nasopharyngitis—Doxorubicin—bone cancer	0.000269	0.00215	CcSEcCtD
Enalapril—Depression—Methotrexate—bone cancer	0.000267	0.00214	CcSEcCtD
Enalapril—Pancytopenia—Epirubicin—bone cancer	0.000267	0.00214	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000266	0.00212	CcSEcCtD
Enalapril—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000266	0.00212	CcSEcCtD
Enalapril—Renal failure—Methotrexate—bone cancer	0.000263	0.00211	CcSEcCtD
Enalapril—Neutropenia—Epirubicin—bone cancer	0.000263	0.0021	CcSEcCtD
Enalapril—Dysuria—Epirubicin—bone cancer	0.000263	0.0021	CcSEcCtD
Enalapril—Upper respiratory tract infection—Epirubicin—bone cancer	0.000261	0.00209	CcSEcCtD
Enalapril—Stomatitis—Methotrexate—bone cancer	0.000261	0.00209	CcSEcCtD
Enalapril—Conjunctivitis—Methotrexate—bone cancer	0.000261	0.00208	CcSEcCtD
Enalapril—Influenza—Doxorubicin—bone cancer	0.00026	0.00208	CcSEcCtD
Enalapril—Asthma—Doxorubicin—bone cancer	0.00026	0.00208	CcSEcCtD
Enalapril—Dysphagia—Doxorubicin—bone cancer	0.00026	0.00208	CcSEcCtD
Enalapril—Pollakiuria—Epirubicin—bone cancer	0.00026	0.00208	CcSEcCtD
Enalapril—Eosinophilia—Doxorubicin—bone cancer	0.000258	0.00206	CcSEcCtD
Enalapril—Photosensitivity reaction—Epirubicin—bone cancer	0.000257	0.00205	CcSEcCtD
Enalapril—Feeling abnormal—Cisplatin—bone cancer	0.000257	0.00205	CcSEcCtD
Enalapril—Pancreatitis—Doxorubicin—bone cancer	0.000255	0.00204	CcSEcCtD
Enalapril—Hyperglycaemia—Epirubicin—bone cancer	0.000254	0.00203	CcSEcCtD
Enalapril—Angina pectoris—Doxorubicin—bone cancer	0.000254	0.00203	CcSEcCtD
Enalapril—Epistaxis—Methotrexate—bone cancer	0.000253	0.00202	CcSEcCtD
Enalapril—Pneumonia—Epirubicin—bone cancer	0.000252	0.00202	CcSEcCtD
Enalapril—Bronchitis—Doxorubicin—bone cancer	0.00025	0.002	CcSEcCtD
Enalapril—Agranulocytosis—Methotrexate—bone cancer	0.00025	0.002	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000249	0.00199	CcSEcCtD
Enalapril—Pancytopenia—Doxorubicin—bone cancer	0.000247	0.00198	CcSEcCtD
Enalapril—Renal failure—Epirubicin—bone cancer	0.000247	0.00197	CcSEcCtD
Enalapril—Body temperature increased—Cisplatin—bone cancer	0.000246	0.00197	CcSEcCtD
Enalapril—Neuropathy peripheral—Epirubicin—bone cancer	0.000246	0.00196	CcSEcCtD
Enalapril—Jaundice—Epirubicin—bone cancer	0.000244	0.00195	CcSEcCtD
Enalapril—Stomatitis—Epirubicin—bone cancer	0.000244	0.00195	CcSEcCtD
Enalapril—Conjunctivitis—Epirubicin—bone cancer	0.000244	0.00195	CcSEcCtD
Enalapril—Urinary tract infection—Epirubicin—bone cancer	0.000244	0.00195	CcSEcCtD
Enalapril—Dysuria—Doxorubicin—bone cancer	0.000243	0.00195	CcSEcCtD
Enalapril—Neutropenia—Doxorubicin—bone cancer	0.000243	0.00195	CcSEcCtD
Enalapril—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000242	0.00193	CcSEcCtD
Enalapril—Hepatitis—Methotrexate—bone cancer	0.000241	0.00192	CcSEcCtD
Enalapril—Pollakiuria—Doxorubicin—bone cancer	0.00024	0.00192	CcSEcCtD
Enalapril—Pharyngitis—Methotrexate—bone cancer	0.000239	0.00191	CcSEcCtD
Enalapril—Photosensitivity reaction—Doxorubicin—bone cancer	0.000238	0.0019	CcSEcCtD
Enalapril—Epistaxis—Epirubicin—bone cancer	0.000237	0.00189	CcSEcCtD
Enalapril—Sinusitis—Epirubicin—bone cancer	0.000235	0.00188	CcSEcCtD
Enalapril—Hyperglycaemia—Doxorubicin—bone cancer	0.000235	0.00188	CcSEcCtD
Enalapril—Agranulocytosis—Epirubicin—bone cancer	0.000234	0.00187	CcSEcCtD
Enalapril—Pneumonia—Doxorubicin—bone cancer	0.000233	0.00187	CcSEcCtD
Enalapril—Visual impairment—Methotrexate—bone cancer	0.000232	0.00185	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00023	0.00184	CcSEcCtD
Enalapril—Hypersensitivity—Cisplatin—bone cancer	0.00023	0.00183	CcSEcCtD
Enalapril—Bradycardia—Epirubicin—bone cancer	0.000229	0.00183	CcSEcCtD
Enalapril—Renal failure—Doxorubicin—bone cancer	0.000228	0.00182	CcSEcCtD
Enalapril—Erythema multiforme—Methotrexate—bone cancer	0.000228	0.00182	CcSEcCtD
Enalapril—Neuropathy peripheral—Doxorubicin—bone cancer	0.000228	0.00182	CcSEcCtD
Enalapril—Stomatitis—Doxorubicin—bone cancer	0.000226	0.00181	CcSEcCtD
Enalapril—Jaundice—Doxorubicin—bone cancer	0.000226	0.00181	CcSEcCtD
Enalapril—Conjunctivitis—Doxorubicin—bone cancer	0.000226	0.0018	CcSEcCtD
Enalapril—Urinary tract infection—Doxorubicin—bone cancer	0.000226	0.0018	CcSEcCtD
Enalapril—Hepatitis—Epirubicin—bone cancer	0.000225	0.0018	CcSEcCtD
Enalapril—Tinnitus—Methotrexate—bone cancer	0.000224	0.00179	CcSEcCtD
Enalapril—Asthenia—Cisplatin—bone cancer	0.000224	0.00179	CcSEcCtD
Enalapril—Pharyngitis—Epirubicin—bone cancer	0.000223	0.00179	CcSEcCtD
Enalapril—Epistaxis—Doxorubicin—bone cancer	0.000219	0.00175	CcSEcCtD
Enalapril—Sinusitis—Doxorubicin—bone cancer	0.000218	0.00174	CcSEcCtD
Enalapril—Visual impairment—Epirubicin—bone cancer	0.000217	0.00173	CcSEcCtD
Enalapril—Agranulocytosis—Doxorubicin—bone cancer	0.000217	0.00173	CcSEcCtD
Enalapril—Diarrhoea—Cisplatin—bone cancer	0.000213	0.0017	CcSEcCtD
Enalapril—Erythema multiforme—Epirubicin—bone cancer	0.000213	0.0017	CcSEcCtD
Enalapril—Alopecia—Methotrexate—bone cancer	0.000213	0.0017	CcSEcCtD
Enalapril—Bradycardia—Doxorubicin—bone cancer	0.000212	0.0017	CcSEcCtD
Enalapril—Tinnitus—Epirubicin—bone cancer	0.00021	0.00168	CcSEcCtD
Enalapril—Erythema—Methotrexate—bone cancer	0.000209	0.00167	CcSEcCtD
Enalapril—Flushing—Epirubicin—bone cancer	0.000209	0.00167	CcSEcCtD
Enalapril—Hepatitis—Doxorubicin—bone cancer	0.000208	0.00167	CcSEcCtD
Enalapril—Pharyngitis—Doxorubicin—bone cancer	0.000207	0.00165	CcSEcCtD
Enalapril—Dysgeusia—Methotrexate—bone cancer	0.000205	0.00164	CcSEcCtD
Enalapril—Back pain—Methotrexate—bone cancer	0.000203	0.00162	CcSEcCtD
Enalapril—Arrhythmia—Epirubicin—bone cancer	0.000201	0.00161	CcSEcCtD
Enalapril—Visual impairment—Doxorubicin—bone cancer	0.000201	0.0016	CcSEcCtD
Enalapril—Alopecia—Epirubicin—bone cancer	0.000199	0.00159	CcSEcCtD
Enalapril—Vomiting—Cisplatin—bone cancer	0.000198	0.00158	CcSEcCtD
Enalapril—Vision blurred—Methotrexate—bone cancer	0.000197	0.00158	CcSEcCtD
Enalapril—Erythema multiforme—Doxorubicin—bone cancer	0.000197	0.00157	CcSEcCtD
Enalapril—Rash—Cisplatin—bone cancer	0.000196	0.00157	CcSEcCtD
Enalapril—Dermatitis—Cisplatin—bone cancer	0.000196	0.00157	CcSEcCtD
Enalapril—Erythema—Epirubicin—bone cancer	0.000196	0.00157	CcSEcCtD
Enalapril—Tinnitus—Doxorubicin—bone cancer	0.000194	0.00155	CcSEcCtD
Enalapril—Anaemia—Methotrexate—bone cancer	0.000194	0.00155	CcSEcCtD
Enalapril—Flushing—Doxorubicin—bone cancer	0.000193	0.00155	CcSEcCtD
Enalapril—Flatulence—Epirubicin—bone cancer	0.000193	0.00154	CcSEcCtD
Enalapril—Tension—Epirubicin—bone cancer	0.000192	0.00154	CcSEcCtD
Enalapril—Dysgeusia—Epirubicin—bone cancer	0.000192	0.00153	CcSEcCtD
Enalapril—Nervousness—Epirubicin—bone cancer	0.00019	0.00152	CcSEcCtD
Enalapril—Back pain—Epirubicin—bone cancer	0.00019	0.00152	CcSEcCtD
Enalapril—Muscle spasms—Epirubicin—bone cancer	0.000188	0.00151	CcSEcCtD
Enalapril—Vertigo—Methotrexate—bone cancer	0.000188	0.0015	CcSEcCtD
Enalapril—Leukopenia—Methotrexate—bone cancer	0.000187	0.0015	CcSEcCtD
Enalapril—Arrhythmia—Doxorubicin—bone cancer	0.000186	0.00149	CcSEcCtD
Enalapril—Nausea—Cisplatin—bone cancer	0.000185	0.00148	CcSEcCtD
Enalapril—Vision blurred—Epirubicin—bone cancer	0.000185	0.00148	CcSEcCtD
Enalapril—Alopecia—Doxorubicin—bone cancer	0.000184	0.00147	CcSEcCtD
Enalapril—Cough—Methotrexate—bone cancer	0.000183	0.00146	CcSEcCtD
Enalapril—Erythema—Doxorubicin—bone cancer	0.000181	0.00145	CcSEcCtD
Enalapril—Anaemia—Epirubicin—bone cancer	0.000181	0.00145	CcSEcCtD
Enalapril—Agitation—Epirubicin—bone cancer	0.00018	0.00144	CcSEcCtD
Enalapril—Flatulence—Doxorubicin—bone cancer	0.000179	0.00143	CcSEcCtD
Enalapril—Chest pain—Methotrexate—bone cancer	0.000178	0.00143	CcSEcCtD
Enalapril—Myalgia—Methotrexate—bone cancer	0.000178	0.00143	CcSEcCtD
Enalapril—Arthralgia—Methotrexate—bone cancer	0.000178	0.00143	CcSEcCtD
Enalapril—Tension—Doxorubicin—bone cancer	0.000178	0.00142	CcSEcCtD
Enalapril—Dysgeusia—Doxorubicin—bone cancer	0.000178	0.00142	CcSEcCtD
Enalapril—Discomfort—Methotrexate—bone cancer	0.000176	0.00141	CcSEcCtD
Enalapril—Nervousness—Doxorubicin—bone cancer	0.000176	0.00141	CcSEcCtD
Enalapril—Vertigo—Epirubicin—bone cancer	0.000176	0.00141	CcSEcCtD
Enalapril—Syncope—Epirubicin—bone cancer	0.000176	0.0014	CcSEcCtD
Enalapril—Leukopenia—Epirubicin—bone cancer	0.000175	0.0014	CcSEcCtD
Enalapril—Back pain—Doxorubicin—bone cancer	0.000175	0.0014	CcSEcCtD
Enalapril—Muscle spasms—Doxorubicin—bone cancer	0.000174	0.00139	CcSEcCtD
Enalapril—Palpitations—Epirubicin—bone cancer	0.000173	0.00138	CcSEcCtD
Enalapril—Confusional state—Methotrexate—bone cancer	0.000172	0.00138	CcSEcCtD
Enalapril—Loss of consciousness—Epirubicin—bone cancer	0.000172	0.00138	CcSEcCtD
Enalapril—Cough—Epirubicin—bone cancer	0.000171	0.00137	CcSEcCtD
Enalapril—Anaphylactic shock—Methotrexate—bone cancer	0.000171	0.00137	CcSEcCtD
Enalapril—Vision blurred—Doxorubicin—bone cancer	0.000171	0.00137	CcSEcCtD
Enalapril—Anaemia—Doxorubicin—bone cancer	0.000168	0.00134	CcSEcCtD
Enalapril—Thrombocytopenia—Methotrexate—bone cancer	0.000167	0.00134	CcSEcCtD
Enalapril—Arthralgia—Epirubicin—bone cancer	0.000167	0.00133	CcSEcCtD
Enalapril—Chest pain—Epirubicin—bone cancer	0.000167	0.00133	CcSEcCtD
Enalapril—Myalgia—Epirubicin—bone cancer	0.000167	0.00133	CcSEcCtD
Enalapril—Agitation—Doxorubicin—bone cancer	0.000167	0.00133	CcSEcCtD
Enalapril—Hyperhidrosis—Methotrexate—bone cancer	0.000165	0.00132	CcSEcCtD
Enalapril—Discomfort—Epirubicin—bone cancer	0.000165	0.00132	CcSEcCtD
Enalapril—Dry mouth—Epirubicin—bone cancer	0.000163	0.0013	CcSEcCtD
Enalapril—Vertigo—Doxorubicin—bone cancer	0.000163	0.0013	CcSEcCtD
Enalapril—Anorexia—Methotrexate—bone cancer	0.000163	0.0013	CcSEcCtD
Enalapril—Syncope—Doxorubicin—bone cancer	0.000163	0.0013	CcSEcCtD
Enalapril—Leukopenia—Doxorubicin—bone cancer	0.000162	0.0013	CcSEcCtD
Enalapril—Confusional state—Epirubicin—bone cancer	0.000161	0.00129	CcSEcCtD
Enalapril—Palpitations—Doxorubicin—bone cancer	0.00016	0.00128	CcSEcCtD
Enalapril—Anaphylactic shock—Epirubicin—bone cancer	0.00016	0.00128	CcSEcCtD
Enalapril—Oedema—Epirubicin—bone cancer	0.00016	0.00128	CcSEcCtD
Enalapril—Hypotension—Methotrexate—bone cancer	0.00016	0.00128	CcSEcCtD
Enalapril—Loss of consciousness—Doxorubicin—bone cancer	0.000159	0.00127	CcSEcCtD
Enalapril—Cough—Doxorubicin—bone cancer	0.000158	0.00126	CcSEcCtD
Enalapril—Shock—Epirubicin—bone cancer	0.000157	0.00126	CcSEcCtD
Enalapril—Thrombocytopenia—Epirubicin—bone cancer	0.000157	0.00125	CcSEcCtD
Enalapril—Tachycardia—Epirubicin—bone cancer	0.000156	0.00125	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000156	0.00124	CcSEcCtD
Enalapril—Hyperhidrosis—Epirubicin—bone cancer	0.000155	0.00124	CcSEcCtD
Enalapril—Insomnia—Methotrexate—bone cancer	0.000155	0.00124	CcSEcCtD
Enalapril—Arthralgia—Doxorubicin—bone cancer	0.000154	0.00123	CcSEcCtD
Enalapril—Chest pain—Doxorubicin—bone cancer	0.000154	0.00123	CcSEcCtD
Enalapril—Myalgia—Doxorubicin—bone cancer	0.000154	0.00123	CcSEcCtD
Enalapril—Paraesthesia—Methotrexate—bone cancer	0.000154	0.00123	CcSEcCtD
Enalapril—Discomfort—Doxorubicin—bone cancer	0.000153	0.00122	CcSEcCtD
Enalapril—Anorexia—Epirubicin—bone cancer	0.000152	0.00122	CcSEcCtD
Enalapril—Dyspnoea—Methotrexate—bone cancer	0.000152	0.00122	CcSEcCtD
Enalapril—Somnolence—Methotrexate—bone cancer	0.000152	0.00121	CcSEcCtD
Enalapril—Dry mouth—Doxorubicin—bone cancer	0.000151	0.00121	CcSEcCtD
Enalapril—Dyspepsia—Methotrexate—bone cancer	0.00015	0.0012	CcSEcCtD
Enalapril—Hypotension—Epirubicin—bone cancer	0.000149	0.00119	CcSEcCtD
Enalapril—Confusional state—Doxorubicin—bone cancer	0.000149	0.00119	CcSEcCtD
Enalapril—Decreased appetite—Methotrexate—bone cancer	0.000149	0.00119	CcSEcCtD
Enalapril—Anaphylactic shock—Doxorubicin—bone cancer	0.000148	0.00118	CcSEcCtD
Enalapril—Oedema—Doxorubicin—bone cancer	0.000148	0.00118	CcSEcCtD
Enalapril—Fatigue—Methotrexate—bone cancer	0.000147	0.00118	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000146	0.00116	CcSEcCtD
Enalapril—Shock—Doxorubicin—bone cancer	0.000146	0.00116	CcSEcCtD
Enalapril—Thrombocytopenia—Doxorubicin—bone cancer	0.000145	0.00116	CcSEcCtD
Enalapril—Insomnia—Epirubicin—bone cancer	0.000145	0.00116	CcSEcCtD
Enalapril—Tachycardia—Doxorubicin—bone cancer	0.000144	0.00115	CcSEcCtD
Enalapril—Paraesthesia—Epirubicin—bone cancer	0.000144	0.00115	CcSEcCtD
Enalapril—Hyperhidrosis—Doxorubicin—bone cancer	0.000143	0.00114	CcSEcCtD
Enalapril—Dyspnoea—Epirubicin—bone cancer	0.000143	0.00114	CcSEcCtD
Enalapril—Somnolence—Epirubicin—bone cancer	0.000142	0.00114	CcSEcCtD
Enalapril—Anorexia—Doxorubicin—bone cancer	0.000141	0.00113	CcSEcCtD
Enalapril—Feeling abnormal—Methotrexate—bone cancer	0.000141	0.00113	CcSEcCtD
Enalapril—Dyspepsia—Epirubicin—bone cancer	0.000141	0.00113	CcSEcCtD
Enalapril—Gastrointestinal pain—Methotrexate—bone cancer	0.00014	0.00112	CcSEcCtD
Enalapril—Decreased appetite—Epirubicin—bone cancer	0.000139	0.00111	CcSEcCtD
Enalapril—Hypotension—Doxorubicin—bone cancer	0.000138	0.00111	CcSEcCtD
Enalapril—Fatigue—Epirubicin—bone cancer	0.000138	0.0011	CcSEcCtD
Enalapril—Constipation—Epirubicin—bone cancer	0.000137	0.00109	CcSEcCtD
Enalapril—Urticaria—Methotrexate—bone cancer	0.000136	0.00109	CcSEcCtD
Enalapril—Abdominal pain—Methotrexate—bone cancer	0.000135	0.00108	CcSEcCtD
Enalapril—Body temperature increased—Methotrexate—bone cancer	0.000135	0.00108	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000135	0.00108	CcSEcCtD
Enalapril—Insomnia—Doxorubicin—bone cancer	0.000134	0.00107	CcSEcCtD
Enalapril—Paraesthesia—Doxorubicin—bone cancer	0.000133	0.00106	CcSEcCtD
Enalapril—Dyspnoea—Doxorubicin—bone cancer	0.000132	0.00105	CcSEcCtD
Enalapril—Feeling abnormal—Epirubicin—bone cancer	0.000132	0.00105	CcSEcCtD
Enalapril—Somnolence—Doxorubicin—bone cancer	0.000132	0.00105	CcSEcCtD
Enalapril—Gastrointestinal pain—Epirubicin—bone cancer	0.000131	0.00105	CcSEcCtD
Enalapril—Dyspepsia—Doxorubicin—bone cancer	0.00013	0.00104	CcSEcCtD
Enalapril—Decreased appetite—Doxorubicin—bone cancer	0.000129	0.00103	CcSEcCtD
Enalapril—Fatigue—Doxorubicin—bone cancer	0.000128	0.00102	CcSEcCtD
Enalapril—Urticaria—Epirubicin—bone cancer	0.000127	0.00102	CcSEcCtD
Enalapril—Constipation—Doxorubicin—bone cancer	0.000127	0.00101	CcSEcCtD
Enalapril—Abdominal pain—Epirubicin—bone cancer	0.000126	0.00101	CcSEcCtD
Enalapril—Body temperature increased—Epirubicin—bone cancer	0.000126	0.00101	CcSEcCtD
Enalapril—Hypersensitivity—Methotrexate—bone cancer	0.000126	0.00101	CcSEcCtD
Enalapril—Asthenia—Methotrexate—bone cancer	0.000123	0.00098	CcSEcCtD
Enalapril—Feeling abnormal—Doxorubicin—bone cancer	0.000122	0.000975	CcSEcCtD
Enalapril—Gastrointestinal pain—Doxorubicin—bone cancer	0.000121	0.000967	CcSEcCtD
Enalapril—Pruritus—Methotrexate—bone cancer	0.000121	0.000967	CcSEcCtD
Enalapril—Hypersensitivity—Epirubicin—bone cancer	0.000118	0.000942	CcSEcCtD
Enalapril—Urticaria—Doxorubicin—bone cancer	0.000118	0.00094	CcSEcCtD
Enalapril—Body temperature increased—Doxorubicin—bone cancer	0.000117	0.000935	CcSEcCtD
Enalapril—Abdominal pain—Doxorubicin—bone cancer	0.000117	0.000935	CcSEcCtD
Enalapril—Diarrhoea—Methotrexate—bone cancer	0.000117	0.000935	CcSEcCtD
Enalapril—Asthenia—Epirubicin—bone cancer	0.000115	0.000917	CcSEcCtD
Enalapril—Pruritus—Epirubicin—bone cancer	0.000113	0.000905	CcSEcCtD
Enalapril—Dizziness—Methotrexate—bone cancer	0.000113	0.000903	CcSEcCtD
Enalapril—Diarrhoea—Epirubicin—bone cancer	0.000109	0.000875	CcSEcCtD
Enalapril—Hypersensitivity—Doxorubicin—bone cancer	0.000109	0.000872	CcSEcCtD
Enalapril—Vomiting—Methotrexate—bone cancer	0.000109	0.000869	CcSEcCtD
Enalapril—Rash—Methotrexate—bone cancer	0.000108	0.000861	CcSEcCtD
Enalapril—Dermatitis—Methotrexate—bone cancer	0.000108	0.000861	CcSEcCtD
Enalapril—Headache—Methotrexate—bone cancer	0.000107	0.000856	CcSEcCtD
Enalapril—Asthenia—Doxorubicin—bone cancer	0.000106	0.000849	CcSEcCtD
Enalapril—Dizziness—Epirubicin—bone cancer	0.000106	0.000845	CcSEcCtD
Enalapril—Pruritus—Doxorubicin—bone cancer	0.000105	0.000837	CcSEcCtD
Enalapril—Vomiting—Epirubicin—bone cancer	0.000102	0.000813	CcSEcCtD
Enalapril—Nausea—Methotrexate—bone cancer	0.000102	0.000811	CcSEcCtD
Enalapril—Diarrhoea—Doxorubicin—bone cancer	0.000101	0.000809	CcSEcCtD
Enalapril—Rash—Epirubicin—bone cancer	0.000101	0.000806	CcSEcCtD
Enalapril—Dermatitis—Epirubicin—bone cancer	0.000101	0.000805	CcSEcCtD
Enalapril—Headache—Epirubicin—bone cancer	0.0001	0.000801	CcSEcCtD
Enalapril—Dizziness—Doxorubicin—bone cancer	9.79e-05	0.000782	CcSEcCtD
Enalapril—Nausea—Epirubicin—bone cancer	9.5e-05	0.000759	CcSEcCtD
Enalapril—Vomiting—Doxorubicin—bone cancer	9.41e-05	0.000752	CcSEcCtD
Enalapril—Rash—Doxorubicin—bone cancer	9.33e-05	0.000746	CcSEcCtD
Enalapril—Dermatitis—Doxorubicin—bone cancer	9.32e-05	0.000745	CcSEcCtD
Enalapril—Headache—Doxorubicin—bone cancer	9.27e-05	0.000741	CcSEcCtD
Enalapril—Nausea—Doxorubicin—bone cancer	8.79e-05	0.000703	CcSEcCtD
